| PME Stock | | | 250.19 5.25 2.06% |
CTO
Malte Westerhoff is GM CTO of Pro Medicus
| Address | 450 Swan Street, Richmond, VIC, Australia, 3121 |
| Phone | 61 3 9429 8800 |
| Web | https://www.promed.com.au |
Pro Medicus Management Efficiency
The company has return on total asset
(ROA) of
0.3068 % which means that it generated a profit of $0.3068 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity
(ROE) of
0.5072 %, meaning that it generated $0.5072 on every $100 dollars invested by stockholders. Pro Medicus' management efficiency ratios could be used to measure how well Pro Medicus manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Pro Medicus'
Total Current Liabilities is comparatively stable compared to the past year.
Liabilities And Stockholders Equity is likely to gain to about 270.3
M in 2024, whereas
Non Current Liabilities Other is likely to drop slightly above 77.5
K in 2024.
Pro Medicus (PME) is traded on Australian Securities Exchange in Australia and employs 10 people. Pro Medicus is listed under Health Care Technology category by Fama And French industry classification.
Management Performance
Pro Medicus Leadership Team
Elected by the shareholders, the Pro Medicus' board of directors comprises two types of representatives: Pro Medicus inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Pro. The board's role is to monitor Pro Medicus' management team and ensure that shareholders' interests are well served. Pro Medicus' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Pro Medicus' outside directors are responsible for providing unbiased perspectives on the board's policies.
| BSc BSc, Technology CoFounder | |
| BComm CPA, Chief Officer | |
| Malte Westerhoff, GM CTO | |
| Danny CA, Financial Secretary | |
| Brad Levin, GM Marketing | |
| Sean Lambright, Global Inc | |
| Sharni Redenbach, People Director | |
| Teresa Gschwind, Global Inc | |
| CPA BComm, CFO Sec | |
| MD MBBS, CEO, CoFounder | |
Pro Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Pro Medicus a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Additional Tools for Pro Stock Analysis
When running Pro Medicus' price analysis, check to
measure Pro Medicus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pro Medicus is operating at the current time. Most of Pro Medicus' value examination focuses on studying past and present price action to
predict the probability of Pro Medicus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pro Medicus' price. Additionally, you may evaluate how the addition of Pro Medicus to your portfolios can decrease your overall portfolio volatility.